EMBLEM Technology Transfer

What EMBLEM Technology Transfer does

EMBLEM Technology Transfer GmbH (legally EMBL Enterprise Management Technology Transfer GmbH) is the wholly owned subsidiary and exclusive technology and knowledge transfer arm of the European Molecular Biology Laboratory (EMBL), founded in 1999 and headquartered in Heidelberg, Germany. The company identifies, protects, and commercializes intellectual property generated by EMBL's scientists, alumni, and select third parties, administering a portfolio of more than 1,000 inventions and over 450 patents/copyrights across life sciences sectors including structural biology, genomics, imaging, bioinformatics, drug discovery, and agriculture.

EMBLEM's commercial surface spans four revenue streams: (1) negotiated licensing of EMBL-developed technologies and patents to pharmaceutical, biotechnology, and agricultural companies; (2) molecular biology services and consultancy provided by EMBL scientists; (3) research collaborations with industry partners; and (4) an EMBLEM Software Store that distributes ~20 EMBL-developed scientific tools (e.g., ATSAS for SAXS/SANS analysis, ARP/wARP for protein refinement, FOLD-X for stability prediction, STRING for protein interaction networks, JLib for instrument control) to academic and commercial users globally. The firm also co-founds and supports spin-off companies such as TimeTeller (chronobiology diagnostics), Luvida (AI-driven clinical trial design), Cerelixis (agricultural phytostimulants), and DenovAI (AI antibody discovery).

The company's go-to-market is sales-led and relationship-driven, executed through direct industry outreach, EMBL partnership referrals, entrepreneurial programming (e.g., "From Lab to Launch" events), and ecosystem alliances including Heidelberg Startup Partners, BioInnovation Institute, AION Labs, and the Israel Innovation Authority. Pricing is custom-negotiated on multi-year contracts with no publicly disclosed rates. EMBLEM's customer base spans global pharma/biotech enterprises, public-sector institutions (e.g., NHS Scotland using PopPIPE for AMR surveillance), and early-stage startups operating in life sciences verticals.

Name

EMBLEM Technology Transfer

Legal name

EMBL Enterprise Management Technology Transfer GmbH

Website

https://embl-em.de

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

EMBLEM Technology Transfer GmbH is the exclusive technology transfer subsidiary of the European Molecular Biology Laboratory (EMBL), commercializing a portfolio of 1,000+ inventions and 450+ patents from EMBL research via licensing, services, software distribution, and spin-off formation across global life sciences markets.

Ownership category

akta.pro rank

Product category

Technology Transfer Services

NAICS

Management, Scientific, and Technical Consulting Services (5416), Software Publishers (513210)

SIC

Patent Owners & Lessors (6794), Miscellaneous Publishing (2741)

akta.pro primary industry

IP Licensing, Transactions & Technology Transfer (BPAHAMAF)

akta.pro secondary industry

Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)

Keywords

• Technology transfer services
• Intellectual property licensing
• Life sciences patents
• Molecular biology services
• Bioinformatics software

Headquarters

HQ city

Heidelberg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Technology Licensing: EMBLEM offers licenses to an extensive portfolio of technologies from various sectors of life sciences. Licensing fees are negotiated for access to EMBL-developed technologies and patents.
2. Molecular Biology Services: Provision of state-of-the-art molecular biology services to industry partners and clients requiring access to EMBL expertise and facilities.
3. Research Collaborations: Consultancy by EMBL scientists and research collaborations with external organizations seeking to leverage EMBL's scientific expertise.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

EMBLEM Technology Transfer GmbH identifies, protects, and commercializes intellectual property developed at the European Molecular Biology Laboratory (EMBL). The company manages a portfolio of more than 1,000 inventions and over 450 patents/copyrights, licensing life sciences technologies to industry partners and providing access to molecular biology services, consultancy by EMBL scientists, and research collaborations. EMBLEM also distributes a suite of scientific software tools (structural biology, bioinformatics, microscopy, and systems biology applications) through its own software store and supports the creation of spin-off companies based on EMBL research.

Product overview

EMBLEM Technology Transfer operates a software store distributing scientific software products developed from EMBL research. The portfolio includes structural biology tools (C3D, ARP/wARP, ATSAS, FOLD-X, Agadir, InterPreTs, PolyPhen, TANGO, ViCi), systems biology tools (SmartCell, STRING), bioinformatics resources (SMART, SNPeffect), microscopy and instrument control software (AutoFocusScreen for ZEN, Micropilot, JLib, StaubCom), and cloud services (Embassy Cloud). These products serve academic and commercial users in life sciences research, drug discovery, and structural biology. EMBLEM also manages a portfolio of over 1000 inventions and 450+ patents from EMBL scientists, providing technology transfer and licensing services to industry.

Differentiator

Problem solved

Functional benefit

Brands

• EMBLEM Software Store: A software distribution platform offering EMBL-developed scientific software tools for structural analysis, imaging, instrument control, protein-function analysis, and systems biology.
• INNOVATION WORKS®

Products and services

• Technology Licensing Licensing of an extensive portfolio of life sciences technologies and patents developed at EMBL, negotiated on a case-by-case basis for access to proprietary inventions by pharmaceutical, biotechnology, and life sciences companies.
• Molecular Biology Services State-of-the-art molecular biology services provided to industry partners and clients requiring access to EMBL expertise, facilities, and instrumentation.
• Research Collaborations and Consultancy Consultancy by EMBL scientists and structured research collaborations with external organizations seeking to leverage EMBL's scientific expertise in molecular biology and life sciences.
• Spin-off Company Creation and Support Co-founding and supporting startup companies based on EMBL technologies, including TimeTeller, Luvida, Cerelixis, and DenovAI, providing path to market for research innovations.
• C3D Crystal centering software that automatically locates a crystal and its holder for centering on a goniometer spindle and alignment with an X-ray beam, featuring improved handling of difficult situations like highly transparent crystals.
• Agadir Prediction algorithm based on helix/coil transition theory that predicts the helical behaviour of monomeric peptides, considering short range interactions with parameters for pH, temperature and ionic strength.
• ARP/wARP Automated Refinement Procedure program package for protein structure refinement that combines iterative reciprocal space structure factor refinement with real space model updating.
• ATSAS Program suite for small angle scattering (SAXS/SANS) data analysis and modelling used to study the structure of biological macromolecules in solution.
• FOLD-X Algorithm providing fast and quantitative estimation of interactions contributing to protein stability and for calculating folding pathways of proteins and protein complexes.
• InterPreTs Program to test putative interactions on complexes of known 3D structure determined by experimental structural biology methods such as X-ray crystallography.
• PolyPhen Tool that predicts possible impact of amino acid substitution on the structure and function of human proteins using empirical rules applied to sequence, structure and conservation analysis.
• TANGO Software that predicts protein aggregation based on a statistical mechanics algorithm based on physico-chemical principles of beta-sheet formation.
• ViCi In silico ligand-based drug design software employing shape matching methodologies combined with tools for describing atomic makeup and electrostatic distribution of molecules.
• SmartCell Framework for modelling and simulation of diffusion-reaction networks in a whole-cell context, supporting localisation and diffusion of molecules.
• Embassy Cloud Service enabling data analysis activities alongside EBI public datasets in a secure, private virtual datacenter with flexible configuration.
• AutoFocusScreen for ZEN VBA macro for intuitive setup of complex time-lapse and multiposition experiments on Zeiss confocal microscopes.
• Micropilot Microscopy software that can be rapidly trained to identify cells of interest automatically and automate complex fluorescence microscopy-based imaging assays.
• SMART Simple Modular Architecture Research Tool for identification and annotation of genetically mobile domains and analysis of domain architectures in signaling, extracellular and chromatin-associated proteins.
• SNPeffect

Quantifiable outcome

• 721% increase in polygenic risk scores hosted in PGS Catalog since 2021
• +2 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

14 partnerships are on record, tiered major and core.

• Instruct-ERICmajorStrategic or Co-development Partner · 1 January 2026European research infrastructure providing access to instruments like EasyGrid and EasyGrid Control for the scientific community. Instruct-ERIC coordinates access to high-end technologies for structural biology research.
• NHS Lothian and University of St AndrewsmajorTechnology or Integration · 1 January 2022Collaboration using PopPIPE genomic analysis tool to investigate antibiotic-resistant bacterial infections across hospital wards, revealing transmission clusters and supporting outbreak response.
• Heidelberg Startup Partners e.V.majorStrategic or Co-development Partner · 1 January 2013Association of research and educational organizations from the Heidelberg area including EMBLEM, Technologiepark Heidelberg, and IHK Rhein-Neckar. Provides advice to inventors, founders and young companies, personal consultation in founders' office, seminars, events, access to coach network, and help with business modelling and funding.
• European Molecular Biology Laboratory (EMBL)coreStrategic or Co-development Partner · 1 January 2006EMBL Enterprise Management Technology Transfer GmbH is the wholly owned subsidiary and exclusive technology and knowledge transfer partner of EMBL. EMBLEM manages the commercialization of EMBL's research output, including over 1000 inventions and 450+ patents/copyrights.
• EMBL Crocker Research GroupcoreTechnology or IntegrationResearch collaboration on agrochemical effects on insect populations using EMBL's unique chemical library of 1000+ agrochemicals for large-scale screens on fruit flies, mosquitoes, and butterflies.
• AION LabsmajorStrategic or Co-development PartnerIsrael-based innovation model that created DenovAI startup. AION Labs identifies industry R&D challenges, recruits scientist founders, and supports startup formation with backing from Pfizer, AstraZeneca, Merck, Teva, AWS, Israel Innovation Authority, and Israel Biotech Fund.
• EMBL Grenoble Instrumentation TeamcoreTechnology or IntegrationCollaboration on EasyGrid development including researchers from EMBL sites with expertise in structural and cell biology (Grenoble, Hamburg, Heidelberg) and partner institutes in France (Inserm, Institut Pasteur, Sorbonne Université, IAB).
• EMBL Imaging CentremajorStrategic or Co-development PartnerEMBL IC in Heidelberg received EasyGrid and EasyGrid Control prototypes, integrating these platforms to provide researchers with control over sample vitrification parameters and high-throughput screening capabilities.
• Heidelberg UniversitymajorStrategic or Co-development PartnerCollaboration on deep brain imaging research using three-photon microscopy technique enhanced with AI to track glioblastoma tumor cells, involving neuroscientists, neurooncologists, and AI experts.
• EMBL-EBIcoreStrategic or Co-development PartnerDevelopment and maintenance of the Polygenic Score (PGS) Catalog, the largest open database for polygenic scores with ~27,000 users from over 140 countries. Collaboration with University of Cambridge and GWAS Catalog.
• DESY Start-up OfficemajorStrategic or Co-development PartnerJoint organizer of 'From Lab to Launch' science entrepreneurship event focused on funding pathways for science-based start-ups, bringing together scientists, entrepreneurs, and innovation professionals.
• Helmholtz-Zentrum HereonmajorStrategic or Co-development PartnerJoint organizer of 'From Lab to Launch' science entrepreneurship event supporting technology transfer and startup ecosystem development.
• BioInnovation Institute (BII)majorStrategic or Co-development PartnerCerelixis, the EMBL spin-off developing precision phytostimulants, was selected for BII's prestigious Venture Lab Programme in Copenhagen, receiving funding, facilities, mentorship, and access to life science innovation ecosystem.
• Israel Innovation AuthoritymajorStrategic or Co-development PartnerPartnership providing technology transfer program including grants, terms and conditions for Israeli companies seeking to access EMBL technologies and collaboration opportunities.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Cambridge Enterprise: Technology transfer office of the University of Cambridge. Directly comparable as an academic TTO with a deep life sciences portfolio, active spin-out creation, and significant licensing income.
• CNRS Innovation: The technology transfer subsidiary of France's CNRS. Directly comparable as a European public-research TTO managing patent portfolios, licensing, and spin-off support across the life sciences and physical sciences.
• Oxford University Innovation: Technology transfer office of the University of Oxford. Directly comparable as an academic TTO with a strong life sciences licensing and spin-out formation franchise, including notable biotech exits.
• LifeArc: UK-based medical research charity and tech transfer organization previously known as MRC Technology. Directly comparable as a life sciences-focused technology transfer and spin-out creation entity operating across academic research.
• Max Planck Innovation: The technology transfer office of the Max Planck Society, performing an identical role to EMBLEM but for the Max Planck Institutes. Directly comparable as a German academic TTO licensing life sciences and physics inventions and supporting spin-offs.
• Ascenion: Technology transfer partner for the Helmholtz Center Munich and life science institutes. Directly comparable as a German life sciences TTO managing invention portfolios, licensing, and spin-off formation.
• Institut Pasteur – Pasteur+: Commercial subsidiary of the Institut Pasteur focused on technology transfer and industrial partnerships. Directly comparable as a European research-institute TTO in life sciences.

Others

• EMBL Ventures: Venture capital firm investing in EMBL-affiliated life sciences companies. Related to EMBLEM and explicitly listed as a 'Related Organisation' on EMBLEM's site, but operates as an investor rather than a tech transfer office.
• BioInnovation Institute (BII): Life sciences innovation hub in Copenhagen that supports EMBL spin-offs (e.g., Cerelixis) through its Venture Lab program. Adjacent as an incubator/accelerator providing funding and facilities to EMBL-derived startups.

Broad incumbents

• Fraunhofer: Germany's largest applied research organization with extensive licensing and spin-out activity. A broader incumbent operating at much greater scale across multiple disciplines, but with overlapping life sciences and biotech technology transfer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/embl-enterprise-management-technology-transfer-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EMBLEM Technology Transfer